Yian Fang

机构：Peking University, National Institutes of Pharmaceutical Research and Development (China), State Key Laboratory of Natural and Biomimetic Drugs · ORCID：0000-0002-0906-7434

发表论文 15 篇 · 总被引 60 次 · h-index 5

代表论文

• mRNA-Based FRET-FLIM Imaging Platform for Quantifying Lipid Nanoparticle Endosomal Escape and Membrane Damage (2025 · Journal of the American Chemical Society · 被引 14)
• Risks, Epidemics, and Prevention Measures of Infectious Diseases in Major Sports Events: Scoping Review (2022 · JMIR Public Health and Surveillance · 被引 13)
• Disparities in cardiovascular disease prevalence among middle-aged and older adults: Roles of socioeconomic position, social connection, and behavioral and physiological risk factors (2022 · Frontiers in Cardiovascular Medicine · 被引 9)
• Direct-to-Consumer Telemedicine Platforms in China: A National Market Survey and Quality Evaluation (2021 · SSRN Electronic Journal · 被引 8)
• Mitigating donor interests in the case of COVID-19 vaccine: the implication of COVAX and DAC membership (2023 · BMJ Global Health · 被引 6)
• Are Rural Primary Care Providers Able to Competently Manage Common Illnesses? A Cross-Sectional Study in Rural Sichuan, Western China (2022 · Healthcare · 被引 3)